Astera Labs, Inc. (NASDAQ:ALAB) Receives Average Rating of “Moderate Buy” from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are presently covering the stock, MarketBeat reports. Eleven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $244.75.

ALAB has been the topic of a number of research reports. TD Cowen boosted their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. Bank of America boosted their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Loop Capital initiated coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective on the stock. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th.

Insider Buying and Selling

In other news, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at $945,868,091.84. This represents a 0.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,161,256 shares of company stock worth $459,844,296. 10.40% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Glenmede Trust Co. NA increased its position in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the last quarter. Lido Advisors LLC boosted its stake in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the period. Perigon Wealth Management LLC boosted its stake in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after purchasing an additional 73 shares during the period. Clearstead Advisors LLC boosted its stake in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after purchasing an additional 76 shares during the period. Finally, Sound Income Strategies LLC lifted its position in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $397.02 on Wednesday. The business’s fifty day moving average price is $275.59 and its two-hundred day moving average price is $191.30. The company has a market capitalization of $68.05 billion, a P/E ratio of 268.26, a PEG ratio of 5.82 and a beta of 3.95. Astera Labs has a 1-year low of $84.78 and a 1-year high of $440.99.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs will post 1.84 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.